These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7491347)

  • 1. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis].
    Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A
    Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microthrombus formation on hemodialysis membranes: a placebo controlled randomized trail of two doses of Indobufen.
    Salter MC; Mayor P; Crow MJ; Rajah SM; Davison AM
    Clin Nephrol; 1985 Jul; 24(1):31-6. PubMed ID: 3893815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of indobufen on leukocyte-dependent thrombocyte aggregation in patients with ischemic heart disease].
    Liusov VA; Diukov IV; Uteshev DV
    Kardiologiia; 1993; 33(4):22-3. PubMed ID: 7933785
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.
    Davì G; Patrono C; Catalano I; Custro N; Giammarresi C; Ganci A; Cosentino F; Notarbartolo A
    Arterioscler Thromb; 1993 Sep; 13(9):1346-9. PubMed ID: 8364018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach.
    Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V
    Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of indobufen.
    Pogliani EM; Colombi M; Cristoforetti G; Valenti G; Miradoli R; Buccianti G
    Pharmatherapeutica; 1982; 3(2):127-32. PubMed ID: 6179101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of 40 K protein phosphorylation in platelet by a new antithrombotic agent, d-indobufen.
    Mamiya S; Hagiwara M; Ishikawa T; Hidaka H
    Thromb Res; 1989 Jun; 54(5):447-56. PubMed ID: 2505401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction.
    Rebuzzi AG; Natale A; Bianchi C; Mariello F; Coppola E; Ciabattoni G
    Eur J Clin Pharmacol; 1990; 39(1):99-100. PubMed ID: 2276396
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and ex vivo effects of indobufen on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Bevilacqua C; Lecchi A; Mannucci PM
    Haemostasis; 1987; 17(5):293-300. PubMed ID: 3666587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiaggregation therapy with ibustrin in patients with ischemic heart diseases].
    Liusov VA; Diukov IV; Uteshev DB; Fomchenkov IV
    Kardiologiia; 1993; 33(4):17-9. PubMed ID: 7933783
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets.
    Dmoszyńska A; Walter-Croneck A; Ledwozyw A
    Thromb Res; 1995 Sep; 79(5-6):483-90. PubMed ID: 7502274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis.
    Luzzatto G; Fabris F; Gerunda GE; Zangrandi F; Girolami A
    Acta Haematol; 1987; 77(2):101-6. PubMed ID: 2955629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
    Vinazzer H; Fuccella LM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indobufen induced modification of phospholipid composition in diabetic platelets.
    Dmoszyńska A; Sokołowska B; Walter-Croneck A; Przesmycki K; Ledwozyw A
    Pol J Pharmacol; 1996; 48(3):331-4. PubMed ID: 9112672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of indobufen on the thrombogenic potential of a Dacron prosthesis in an artificial circulation.
    Sheehan SJ; Monson JR; Salter MC; Rajah DS; Rajah SM; Kester RC
    Eur J Vasc Surg; 1988 Aug; 2(4):223-7. PubMed ID: 2975227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.